Close Menu

NEW YORK(GenomeWeb) – Roche today announced it has signed a definitive agreement to acquire clinical diagnostics firm GeneWeave BioSciences for as much as $425 million.

Under the terms of the agreement, Roche will make a $190 million upfront payment to GeneWeave's shareholders and could pay an additional $235 million in product-related milestones. Once the deal is closed, Roche will integrate GeneWeave into its Molecular Diagnostics unit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.